课题基金 / 基金详情

雄激素信号调控HLA-II差异表达介导Kupffer细胞促炎效应及机制研究

批准号:
81571978
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
邓国宏
学科分类:
肝炎病毒与感染
结题年份:
2019
批准年份:
2015
项目状态:
已结题
项目参与者:
章容、蒋黎、谭文婷、何韦韦、孙舒宁、张娟

项目摘要

结项摘要

项目成果

邓国宏的其他基金

相似基金

相关文献

中文摘要
慢性乙型肝炎病毒(HBV)感染后,肝脏微环境免疫应答及调控是炎症活化与消退的关键环节,但其确切调控机制尚不清楚。最新全基因组关联研究提示,HLA-Ⅱ类基因是影响慢性HBV感染转归最显著的基因。Kupffer细胞在肝脏持续性炎症过程中具有中心调控作用,可表达HLA-Ⅱ类分子提呈抗原,激活CD4 T细胞。雄激素可促进HLA-Ⅱ类分子表达,我们前期发现HLA-Ⅱ类基因启动子存在雄激素反应元件,具有性激素差异转录调控基础。我们推测,雄激素信号可能在转录水平调控HLA-Ⅱ类分子差异表达,进而调控CD4 T细胞极化和Kupffer细胞表型可塑性。本课题拟从雄激素水平、HLA-Ⅱ类分子差异转录、Kupffer细胞表型可塑性调控、CD4 T细胞极化效应等层次,探索雄激素调控Kupffer细胞表达HLA-Ⅱ分子及其促炎效应的机制,以期对肝脏持续性炎症的转归机制产生新认识,为慢性乙型肝炎防治提供有效干预靶点。
英文摘要
HBV-specific CD4 T response and its regulation in liver microenvironment is thought as the key procedure for patients with chronic hepatitis B virus (HBV) infection. However, the exact mechanisms have not been well elucidated. Recently, the genome-wide association studies of ours and other investigators had indicated that HLA class Ⅱ genomic region was the most significant locus for HBV-related chronic liver disease. Kupffer cells are the major regulator in persistent inflammation, which express HLA class Ⅱ molecules and present antigen to CD4 T cells. Androgen could promote the expression of HLA-II molecules, with immunomodulatory effect in the liver microenvironment. Additionally, our preliminary study also showed that there were androgen response elements in the promoter of HLA class Ⅱ gene. So, we hypothesized that the plasticity of HLA-Ⅱ expression (quantity, species, patterns and differentiated allelic combinations) may regulate the plasticity of Kupffer cells and the polarization of CD4 T cells during the persistent inflammation in an androgen-dependent manner. In this project, we investigate the regulations of expression patterns of HLA class II on plasticity of Kupffer cells, the androgen-specific transcription of HLA-II molecules, and differential polarization effects of HLA-II molecules on CD4 T cells. This study may elucidate novel mechanisms involved in the outcomes of persistent inflammations in patients with chronic HBV infection, and find out some new targets for the prevention and intervention of chronic liver diseases.
四年间围绕以下任务开展研究:慢乙肝患者血清激素水平及信号通路;人肝内AR表达情况及Kupffer细胞分布;人巨噬细胞HLA-II类分子/AR/雌激素受体表达模式;AR调控人巨噬细胞分化及HLA-II类分子表达的分子机制。取得以下重要发现:1)全基因组关联图谱结果显示,激素定量性状位点、代谢性状决定位点通路与乙型肝炎的主要、次要位点通路存在交互作用;2)人单核细胞不表达AR、雌激素受体ERα及ERβ,其向巨噬细胞分化过程中,三类激素受体表达持续上调;3)AR进入人巨噬细胞细胞核后抑制PPARγ mRNA转录从而抑制PPARγ蛋白表达;4)巨噬细胞促炎性分化伴随着抗原递呈能力的上升(HLA-II类分子上调)及促炎性细胞因子上调。我们的研究首次揭示了AR对于PPARγ的负向调控作用,表明AR可作为抑制巨噬细胞促炎性分化介导的炎症损伤的理想调控靶标:抑制AR既能降低其抗原递呈能力,亦能降低其促炎性细胞因子释放,促其向抑炎、促修复方向分化。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development.
β-防御素 1 在 HCV 感染的肝癌/肝癌中的表达:在保护 HCV 进展和肝癌发展中发挥重要作用
DOI: 10.1038/s41598-017-13332-0
发表时间: 2017-10-17
期刊: Scientific reports
影响因子: 4.6
作者: [Ling YM, Chen JY, Guo L, Wang CY, Tan WT, Wen Q, Zhang SD, Deng GH, Lin Y, Kwok HF]
通讯作者: Kwok HF
Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data.
基于真实临床数据的 PIVKA-II 在肝细胞癌检测中的有效性
DOI: 10.1186/s12885-017-3609-6
发表时间: 2017-09-01
期刊: BMC cancer
影响因子: 3.8
作者: [Yu R, Tan Z, Xiang X, Dan Y, Deng G]
通讯作者: Deng G
DOI: 10.1016/j.cgh.2020.02.037
发表时间: 2020-10-01
期刊: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
影响因子: 12.6
作者: [Zhang, Yan, Xu, Bao-yan, Hua, Jing]
通讯作者: Hua, Jing
Stability of Chronic Hepatitis-Related Parameters in Serum Samples After Long-Term Storage
长期储存后血清样本中慢性肝炎相关参数的稳定性
DOI: --
发表时间: 2017
期刊: Biopreservation And Biobanking
影响因子: 1.6
作者: [Rentao Yu, Yunjie Dan, Xiaomei Xiang, Yi Zhou, Xuemei Kuang, Ge Yang, Yulan Tang, Mingdong Liu, Weilong Kong, Wenting Tan, Guohong Deng]
通讯作者: Guohong Deng
HBV特异性TNF-α+ CD4 Tscm新亚群 介导免疫损伤/保护的机制及干预策略研究
HLA-DR/DQ等位在慢性HBV感染免疫损伤中的作用及机制研究
原发性肝癌大家系遗传变异位点的鉴定及其致病效应研究
ESR1基因内含子1 rSNP的鉴定及其在慢性HBV感染相关肝病中的功能研究
国内基金
海外基金